[Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
The authors describe the results of treatment of four cases of spasmodic paraplegia from Paget's disease of the vertebrae with diphosphonates (EHDP and CL2 MDP). The quality and long duration of the functional results obtained by this new treatment of Paget's disease indicate that medical treatment is essential for the medullary complications of this affection.
D000368:Aged; D002116:Calcitonin / Q000627:therapeutic use; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D012968:Etidronic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000150:complications* / Q000188:drug therapy; D010264:Paraplegia / Q000188:drug therapy* / Q000209:etiology
D004164:Diphosphonates; D004002:Clodronic Acid; D002116:Calcitonin; D012968:Etidronic Acid
Traitement des paraplégies pagétiques par les diphosphonates. Premiers résultats.